Switching between Janus kinase inhibitors for treatment of alopecia areata: A multicenter retrospective review

Key Points

• Treatment response in alopecia areata improved with the strategic switching of Janus kinase inhibitors.
• Alopecia areata patients experienced enhanced hair regrowth when changed to a different Janus kinase inhibitor.
• Retrospective review across multiple centers utilized clinical records to evaluate treatment efficacy.
• Highlighting the potential benefits of personalized therapy strategies for alopecia areata management.